Students in Cornell Engineering's Kessler Fellows program will be embarking on internships with startups across the country this summer and engaging in work from modern beekeeping to designer jewelry subscriptions.
The Cornell Board of Trustees voted May 26 to approve the Paul Rubacha Department of Real Estate, to be managed between the College of Architecture, Art and Planning and the Cornell SC Johnson College of Business.
More than $66 million in scholarship funds, first announced last fall, are opening up possibilities for students across the Cornell SC Johnson College of Business, thanks to the generosity of alumni.
Our 11th episode features Stephanie Wisner ’16, co-founder of Centivax, a therapeutics company that’s creating universal vaccines to reduce and eradicate the remaining complex pathogens of the 21st century.
In a Cornell China Center webinar held May 27, legal scholars based in China, Switzerland and the United States surveyed artificial intelligence regulation across the world, identifying strategic similarities and local distinctions.
Summer Session, running May 31 through August 2, 2022, is open to Cornell and visiting undergraduate and graduate students, high school students and any interested adult. Undergraduates can earn up to 15 credits in on-campus, online, and off-campus courses before the fall semester.
Milk carton “use-by” dates soon may be a quaint relic. A new Cornell study finds that consumers like QR codes, better depicting how long milk is drinkable – creating less food waste.
When a deadly global pandemic broke out, compliance — the act of following rules — became critical. Yet many people didn’t adhere to the rules. Professor John, from the Cornell Law School, explains how getting people to work together and follow rules takes careful thought and planning, and that compliance inside businesses and organizations is essential to accomplishing just about anything.
Cornell startup Antithesis Foods and Bactana were awarded NSF small-business grants, as Guard Medical raises $11 million in Series B investments and C2i launches a disease test in Europe.
